Cooper, B&L Bolstered By Contact Lens Growth; MDDI Index Is Flat In Q3
This article was originally published in The Gray Sheet
The Cooper Companies' plans to develop advanced contact lens products, coupled with raised earnings estimates for fiscal 2003, helped propel a 17.2% rise in the firm's stock price in the third quarter to $40.75, up $5.98
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.